SIGA TECHNOLOGIES INC
About SIGA TECHNOLOGIES INC
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $94.6M
- Net income
- $23.3M
- Total assets
- $219.5M
- Market cap
- $308.4M
- Gross margin
- 68.6%
- Operating margin
- 25.1%
- Net margin
- 24.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $94.6M
- Cost of revenue
- $29.7M
- Gross profit
- $64.9M
- Operating expenses
- $41.2M
- Operating income
- $23.7M
- Income tax
- $7.1M
- Net income
- $23.3M
- EPS (basic)
- $0.33
- EPS (diluted)
- $0.32
Balance sheet
- Total assets
- $219.5M
- Current assets
- $212.9M
- Total liabilities
- $20.6M
- Current liabilities
- $18.0M
- Shareholders’ equity
- $198.8M
Cash flow
- Operating cash flow
- $43.5M
- Investing cash flow
- -$355.0K
- Financing cash flow
- -$43.6M
- Net cash flow
- -$433.8K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $308.4M
- P/E ratio
- 13.5
- EPS (diluted)
- $0.32
- Dividend yield
- 13.86%
- Shares outstanding
- 71.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 9, 1997
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $23.3M in FY2025.
- Revenue declined 29% from FY2021 to FY2025.
- Gross margin of 68.6%, net margin 24.6%.
- Trading 54% below its 52-week high.
- Pays a dividend yielding about 13.86% annually.
- Valued at a price-to-earnings (P/E) ratio of 13.5.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SIGA TECHNOLOGIES INC.
Write a review
News about SIGA TECHNOLOGIES INC
News & sentiment via Polygon.io
